The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Neumayer Matthew Paul since year 2005.
The trader's CIK number is 1476315.
At the time of this reporting, Neumayer Matthew Paul is the Principal Accounting Officer of Osiris Therapeutics, Inc. .
(stock ticker symbol OSIR).
See this page for all insider trading activities at Osiris Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-05-29||OSIR||Osiris Therapeutics, Inc.||Sale||500||15.55||7,775|
|2014-05-29||OSIR||Osiris Therapeutics, Inc.||Option Ex||500||6.46||3,230|
|2014-05-27||OSIR||Osiris Therapeutics, Inc.||Option Ex||3,750||6.92||25,950|
|2014-05-27||OSIR||Osiris Therapeutics, Inc.||Sale||3,750||16.10||60,375|
|2013-08-20||OSIR||Osiris Therapeutics, Inc.||Sale||11,375||19.75||224,656|
|2013-08-20||OSIR||Osiris Therapeutics, Inc.||Option Ex||11,375||8.63||98,189|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Neumayer Matthew Paul (Principal Accounting Officer of Osiris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.